Home>>Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis.

Search

About

Authors:
Address: Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.
Journal:


Publication:


abstract

Matrix metalloproteinase 9 (MMP9) gene has been shown to be involved in the pathogenesis of allergic rhinitis (AR) and asthma. Previous studies suggested that single-nucleotide polymorphisms (SNPs) of the MMP9 gene conferred a risk for childhood asthma. However, whether the SNPs confer a risk for AR has not been previously investigated. The objective of this study was to investigate whether SNPs of the MMP9 gene are associated with risk of seasonal AR (pollinosis), perennial AR and allergen sensitization. A total of 670 school children were recruited in Japan and genotyped for functional polymorphism in the promoter (-1590C/T: rs3918242) and three amino-acid substitutions (R297Q: rs17576; P574R: rs2250889; R668Q: rs17577). Serum levels of total and specific IgE were determined. Disease status and other clinical characteristics of the subjects were investigated using a questionnaire. Associations between the MMP9 SNPs and both AR and serum IgE levels were evaluated. -1590C/T showed significant association with cedar pollinosis (corrected P (Pcor)=0.039). R668Q was in strong linkage disequilibrium (LD) with -1590C/T and showed significant association with cedar pollinosis (Pcor=0.023) and serum cedar pollen-specific IgE level (Pcor=0.022). A haplotype associated with -1590T and 668Q showed a significant association with cedar pollinosis, orchard grass pollinosis and cedar pollen-specific IgE (Pcor=0.0012, Pcor=0.0059 and Pcor=0.0041, respectively). R297Q and P574R were in weak LD with the rest of the SNPs and did not show significant association with disease. Compared with wild-type MMP9 protein (279R-574P-668R), a variant enzyme (279R-574P-668Q) that showed association with pollinosis had lower activity. However, lower enzyme activity was not associated with disease risk because another variant (279Q-574R-668R) showed lower enzyme activity but was not associated with pollinosis. The -1590T allele and its corresponding haplotype was associated with higher promoter activity and with pollen-specific IgE levels and pollinosis, suggesting that -1590C/T may have more impact on sensitization and disease development than R668Q. Our results suggest that the MMP9 gene confers susceptibility to cedar pollinosis in Japanese children. The MMP9 gene may be associated with pollinosis through sensitization processes.



Related Articles
Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen.
Clin Exp Allergy. 2004
Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen.
Cheng L, Enomoto T, Hirota T, Shimizu M, Takahashi N, Akahoshi M, Matsuda A, Dake Y, Doi S, Enomoto K, et al. Clin Exp Allergy. 2004 Aug; 34(8):1192-201.
Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
Clin Exp Allergy. 2008
Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y. Clin Exp Allergy. 2008 Mar; 38(3):405-12. Epub 2007 Dec 7.
[Influence of sensitization to pollen and food allergens on pollinosis clinical symptoms].
Medicina (Kaunas). 2005
[Influence of sensitization to pollen and food allergens on pollinosis clinical symptoms].
Staikūniene J, Japertiene LM, Sakalauskas R. Medicina (Kaunas). 2005; 41(3):208-16.
Review Present situation of cedar pollinosis in Japan and its immune responses.
Allergol Int. 2009
Review Present situation of cedar pollinosis in Japan and its immune responses.
Okamoto Y, Horiguchi S, Yamamoto H, Yonekura S, Hanazawa T. Allergol Int. 2009 Jun; 58(2):155-62. Epub 2009 Mar 25.
Review Anti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab update.
Allergol Int. 2008
Review Anti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab update.
Okubo K, Nagakura T. Allergol Int. 2008 Sep; 57(3):205-9.